Optimizing Molecular Diagnostics for Huntington's Disease and Hemochromatosis

Authors

Keywords:

Molecular diagnosis, Monogenic diseases, Huntington disease, Hemochromatosis

Abstract

The molecular characterization of the mutations causing hereditary diseases are important tools for diagnosis, prognosis and eventually treatment. Huntington's disease is a neurodegenerative disease producing spastic uncontrolled movements and is caused by the expansion of a trinucleotide (CAG)n within the first exon of the gene HD located at 4p16. Hemocromatosis is a liver disease causing cirrosis, diabetes and heart problems, in addition one third of patients dies of hepatocarcinoma. Almost all cases of hemocromatosis are due to mutations in the gene HFE at 6p21, being C282Y and H63D the mutations most frequently detected in Europe and USA. We are establishing the molecular diagnosis of different diseases starting with Huntington disease and hemochromatosis as the begining of a service to the Peruvian comunity.

Downloads

Download data is not yet available.

Published

2022-08-18

How to Cite

1.
Hurtado Alindes A, Guevara-Fujita ML, Acevedo L, Fujita R. Optimizing Molecular Diagnostics for Huntington’s Disease and Hemochromatosis. Horiz Med [Internet]. 2022Aug.18 [cited 2024May19];3(1/2). Available from: https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2017

Issue

Section

Original article

Most read articles by the same author(s)

1 2 > >>